Charles N. York II - 01 Jul 2022 Form 4 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
COO, CFO and Secretary
Signature
/s/ Charles N. York II
Issuer symbol
DAWN
Transactions as of
01 Jul 2022
Net transactions value
-$45,580
Form type
4
Filing time
06 Jul 2022, 21:00:23 UTC
Previous filing
20 Jan 2022
Next filing
12 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DAWN Common Stock Sale $29,580 -1,479 -0.44% $20.00 336,081 01 Jul 2022 Direct F1
transaction DAWN Common Stock Sale $16,000 -800 -0.24% $20.00 335,281 05 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.